Bio

Bio
Dan Zabrowski, Ph.D.
Director

Dan Zabrowski, Ph.D. Dr. Zabrowski will serve as a member of the Combined Company Board upon the consummation of the proposed Business Combination. Dr. Zabrowski has served as a member of Apexigen’s board of directors since July 2016. He has served as a venture partner at Decheng Capital, a venture capital firm, since July 2016. From April 1992 to February 2016 Dr. Zabrowski was with F. Hoffmann-La Roche AG, a healthcare company, where he served in various pharma executive roles and was a member of the Roche Executive Committee. Most recently, Dr. Zabrowski was President of the Roche Sequencing Unit and Tissue Diagnostics, from September 2013 to February 2016. He holds a B.A. in Chemistry from Saint Louis University and a Ph.D. in Organic Chemistry from Indiana University, Bloomington.

Independent Director